The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
UNODC World Drug Report 2016
Around five per cent of the adult population, or nearly 250 million people between the ages of 15 and 64, used at least one drug in 2014, according to the latest World Drug Report released today by the United Nations Office on Drugs and...
International Standards for the Treatment of Drug Use Disorders: Draft for field testing
The International Standards for the Treatment of Drug Use Disorders (Standards) were prepared by UNODC and WHO to support Member States in the development and expansion of treatment services that offer effective and ethical treatment. The...
Pioneering methadone programme gives hope to thousands in Dar es Salaam
In a discreet corner of the Mwananyamala District Hospital grounds, in Dar es Salaam, a group of young people queue up outside a small window to get their daily fix of methadone.
Prescription Drug Monitoring Programs Linked to Reductions in Opioid Overdose Deaths
Implementation of prescription drug monitoring programs was associated with a reduction in opioid-related overdose deaths
EMCDDA Publishes Its First Report on Health Responses to New Psychoactive Substances
Over the last decade, there has been an unprecedented rise in the number of new drugs appearing on the global market
Long-term follow-up of patients treated with buprenorphine/naloxone
In the first long-term follow-up of patients treated with buprenorphine/naloxone (Bp/Nx) for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy. After 3.5 years...
Registration open for fifth European drugs summer school
Illicit drugs in Europe: demand, supply and public policies
From Coercion to Cohesion: Treating Drug Dependence through Health Care, Not Punishment
The aim of this draft discussion paper, “From coercion to cohesion: Treating drug dependence through health care, not punishment”, is to promote a health-oriented approach to drug dependence. The International Drug Control Conventions give...